2,269
Total Publications
175,325
Total Citations
Top Researchers
- Ian Chau 45,072 citations • 847 papers
- Sun Young Rha 34,718 citations • 1307 papers
- Elke Jäger 21,695 citations • 401 papers
- Salah‐Eddin Al‐Batran 17,648 citations • 366 papers
- Julia Karbach 8,910 citations • 170 papers
- Thorsten Oliver Goetze 7,716 citations • 247 papers
- G. Seipelt 6,539 citations • 122 papers
- Thilo Welsch 6,354 citations • 235 papers
- Akin Atmaca 6,165 citations • 108 papers
- Pawel Kermer 5,011 citations • 142 papers
Most Cited Papers
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial 2019 • 2,502 citations
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial 2014 • 1,728 citations
- Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial 2013 • 1,478 citations
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial 2016 • 1,249 citations
- Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164 2019 • 998 citations
- One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor 2012 • 961 citations
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer 2018 • 888 citations
- International consensus statement on the peri‐operative management of anaemia and iron deficiency 2016 • 820 citations
- Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1 1999 • 786 citations
- Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie 2008 • 783 citations